Macrophage Death as a Pharmacological Target in Atherosclerosis
Atherosclerosis is a chronic inflammatory disorder characterized by the gradual build-up of plaques within the vessel wall of middle-sized and large arteries. Over the past decades, treatment of atherosclerosis mainly focused on lowering lipid levels, which can be accomplished by the use of statins....
Saved in:
Main Authors: | Wim Martinet (Author), Isabelle Coornaert (Author), Pauline Puylaert (Author), Guido R. Y. De Meyer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
by: Ping Ping Hu, et al.
Published: (2022) -
Macrophage Autophagy in Atherosclerosis
by: Maria Chiara Maiuri, et al.
Published: (2013) -
Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis
by: Emanuela Fabiola Craparo, et al.
Published: (2021) -
Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
by: Michelle C. Flynn, et al.
Published: (2019) -
Innate immunity and monocyte-macrophage activation in atherosclerosis
by: Davies Alun H, et al.
Published: (2011)